NH - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 4.1
| Stock Code | NH | Market Cap | 37,939 Cr. | Current Price | 1,854 ₹ | High / Low | 2,372 ₹ |
| Stock P/E | 76.8 | Book Value | 114 ₹ | Dividend Yield | 0.24 % | ROCE | 19.4 % |
| ROE | 21.0 % | Face Value | 10.0 ₹ | DMA 50 | 1,801 ₹ | DMA 200 | 1,780 ₹ |
| Chg in FII Hold | -1.12 % | Chg in DII Hold | 1.23 % | PAT Qtr | 109 Cr. | PAT Prev Qtr | 138 Cr. |
| RSI | 54.1 | MACD | 33.7 | Volume | 5,30,223 | Avg Vol 1Wk | 3,99,225 |
| Low price | 1,564 ₹ | High price | 2,372 ₹ | PEG Ratio | 1.66 | Debt to equity | 0.69 |
| 52w Index | 35.9 % | Qtr Profit Var | 37.1 % | EPS | 22.6 ₹ | Industry PE | 47.8 |
📈 Chart & Trend: NH is trading at 1,854 ₹, above both its 50 DMA (1,801 ₹) and 200 DMA (1,780 ₹), reflecting strong technical strength. Support lies at 1,820–1,830 ₹, with resistance around 1,880–1,900 ₹.
🔎 Momentum Signals: RSI at 54.1 indicates balanced momentum leaning bullish. MACD at 33.7 shows a strong positive crossover, confirming upward bias. Entry zone: 1,820–1,830 ₹. Exit zone: 1,880–1,900 ₹.
📊 Volume Trends: Current volume (5.30 Lakh) is above the 1-week average (3.99 Lakh), reflecting strong participation and accumulation interest.
📉 Bollinger Bands: Bands are moderately wide, suggesting volatility expansion with bullish undertones.
📌 Trend Status: The stock is in a short-term uptrend supported by strong technical signals and volume strength.
Positive
- Strong ROE (21.0%) and ROCE (19.4%) highlight efficient capital use.
- Trading above both 50 DMA and 200 DMA confirms bullish technical strength.
- EPS of 22.6 ₹ supports valuation comfort.
- DII holdings increased (+1.23%), showing domestic institutional support.
- Quarterly profit variation (+37.1%) highlights resilience.
Limitation
- High P/E (76.8) compared to industry average (47.8) indicates overvaluation.
- Debt-to-equity ratio of 0.69 reflects moderate leverage.
- Quarterly PAT declined (109 Cr. vs 138 Cr.), showing earnings pressure.
- Dividend yield of 0.24% is modest, limiting income appeal.
Company Negative News
- FII holdings declined (-1.12%), showing reduced foreign investor confidence.
- Sequential PAT decline highlights earnings weakness.
Company Positive News
- DII inflows (+1.23%) reflect strong domestic institutional support.
- Quarterly profit variation (+37.1%) highlights operational resilience despite PAT decline.
Industry
- Industry PE at 47.8 suggests sector is moderately valued compared to NH’s premium valuation.
- Healthcare sector outlook remains positive with rising demand for medical services.
Conclusion
NH is in a short-term uptrend, trading above key moving averages with strong volume support. Fundamentals remain solid with efficient capital use and institutional backing, though high valuation and earnings pressure limit upside. Best suited for cautious entry near 1,820–1,830 ₹ with profit booking around 1,880–1,900 ₹.
NH is positioned in a short-term uptrend with strong technical signals but valuation risks. To enrich this, I can extend into a peer benchmarking analysis or a sector overlay comparison to highlight its relative strength against healthcare peers.